1. Report Introduction 2. Wet Macular Degeneration Overview 3. Pipeline Therapeutics • An Overview of Pipeline Products for Wet Macular Degeneration 4. Comparative Analysis 5. Products in Clinical Stage 5.1 Drug Name : Company Name • Product Description • Research and Development • Product Development Activities 6. Products in Pre-Clinical and Discovery Stage 6.1 Drug Name : Company Name • Product Description • Research and Development • Product Development Activities 7. Therapeutic Assessment • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type 8. Inactive Products 8.1 Drug Name : Company Name • Product Description • Research and Development • Product Development Activities Appendix Report Methodology Consulting Services Disclaimer About DelveInsight

Table 1: Total Products for Wet Macular Degeneration Table 2: Products in Clinical Stage Table 3: Products in Non-clinical Stage Table 4: Assessment by Route of Administration Table 5: Assessment by Stage and Route of Administration Table 6: Assessment by Molecule Type Table 7: Assessment by Stage and Molecule Type Table 8: Inactive Products Figure 1: Total Products for Wet Macular Degeneration Figure 2: Products in Clinical Stage Figure 3: Products in Non-clinical Stage Figure 4: Assessment by Route of Administration Figure 5: Assessment by Stage and Route of Administration Figure 6: Assessment by Molecule Type Figure 7: Assessment by Stage and Molecule Type Figure 8: Inactive Products

Aciont Inc. Adverum Biotechnologies Allergan Plc Alteogen Inc. Amakem NV Ampio Pharmaceuticals Apellis Pharmaceuticals Apexigen Applied Genetic Technologies Corporation Benitec Biopharma Limited Boehringer Ingelheim GmbH Cell Medica Limited Charlesson LLC. Cipla Ltd. Clanotech AB Clearside BioMedical Clonz Biotech Private Limited & list continues...